“Today, three of the authors of the paper, ‘Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis”, have retracted their study,” The Lancet said in a retraction statement Thursday.
“We deeply apologise to you, the editors, and the journal readership for any embarrassment or inconvenience that this may have caused,” the authors of the study wrote.